---
DrugClass: "[[Antianginal and Vasodilating Drugs]]"
SubClass: "[[Agents Used for Pulmonary Arterial Hypertension (PAH)]]"
DrugClassContra: "[[Antianginal and Vasodilating Drugs#Contraindications]]"
DrugClassAdverse: "[[Antianginal and Vasodilating Drugs#Side/Adverse Effects]]"
SecondaryDrugClass: 
SecondarySubClass: 
SecondaryAdverse: 
SecondaryContra: 
ThirdDrugClass: 
ThirdSubClass: 
BrandName: Uptravi
Chapter: "35"
KindleLinkChap: "[Chapter 35](kindle://book?action=open&asin=B09FRF11YJ&location=19375)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
aliases:
---
```smiles

```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`

### Dosage & Usage
PAH
1600 mcg orally twice daily

### Contraindications
See `= this.DrugClassContra`

### Mechanisms of Action


### Side/Adverse Effects
See `= this.DrugClassAdverse`
Headache, nausea, vomiting, diarrhea, jaw/ limb pain, flushing, rash

### Interactions

`= this.ChemLink+this.file.name`

